For readers who have read my articles on China Animal (“CAL”) on sharesinvestment on 12 Apr 10 and 31 Dec 09, you would have been aware that I have been keeping CAL on my KIV list. This is due to the execution risks on its acquisitions of hand, foot, mouth disease (“HFMD”) license and the porcine reproduction and respiratory syndrome (“PRRS”) license, and the difficulties in forecasting the earnings contributions from these licenses. However, much have changed since my last update on CAL. Below are the reasons why CAL is an attractive investment. Investment merits Macro – government policies and […]